Huizhou Health Sciences Polytechnic, Huizhou, China.
Department of Endocrinology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Medicine (Baltimore). 2022 Nov 11;101(45):e31501. doi: 10.1097/MD.0000000000031501.
Previously, a case series study was conducted on our part in which 5 patients with Graves' disease (GD) were collected from a 3-generation family to screen for susceptibility genes responsible for GD. The single nucleotide variants of Microtubule-associated protein 7 domain containing 2 c. 452C > T, p. Ala151Val, Solute carrier family 1 member 7 c. 1204C > T, p. Arg402Cys, tumor necrosis factor receptor-associated factor 3 interacting protein 3 (TRAF3IP3) c. 209A > T, p. Asn70Ile, protein tyrosine phosphatase receptor type B (PTPRB) c. 3472A > G, p. Ser1158Gly, Phosphoinositide-3-kinase regulatory subunit 3 c. 121C > T, p. Pro41Ser, disrupted in schizophrenia 1 (DISC1), c. 1591G > C p. Gly531Arg were associated with the familial GD. We then further confirmed these variants and investigated whether other mutations render susceptibility to GD. The case-control study collected patients with sporadic GD or no GD family history. A snapshot program was used for genotyping the selected SNPs in 235 GD patients (GD group 1) and 284 healthy patients (control group). Furthermore, another 184 GD patients were recruited (GD group 2) to sequence the specified exons of these genes. The sequenced data was compared with Chinese Millionome Database (CMDB). Several variants of PTPRB, phosphoinositide-3-kinase regulatory subunit 3, TRAF3IP3, and DISC1 were found in GD group 2 but not in CMDB. Moreover, the allele frequency of SNP rs2076150 (TRAF3IP3) and rs2492367 DISC1 in GD group 2 was significantly higher than that of in CMDB (all P < .05). When the control group or CMDB was set as a reference group, a significantly higher frequency in alter allele C of SNP rs186466118 PTPRB was observed in GD group 1 and GD group (constituted by GD group 1 and GD group 2). Equally importantly, there was a correlation between the allele C of SNP rs186466118 and the increased risk of GD susceptibility (all P < .05). PTPRB, TRAF3IP3, and DISC1 may be susceptibility genes for GD, and more variants of PTPRB, TRAF3IP3, and DISC1 were found in GD patients.
先前,我们部分进行了一项病例系列研究,从一个三代家族中收集了 5 名格雷夫斯病(GD)患者,以筛选导致 GD 的易感基因。微管相关蛋白 7 结构域包含 2 c.452C>T,p.Ala151Val、溶质载体家族 1 成员 7 c.1204C>T,p.Arg402Cys、肿瘤坏死因子受体相关因子 3 相互作用蛋白 3(TRAF3IP3)c.209A>T,p.Asn70Ile、蛋白酪氨酸磷酸酶受体 B(PTPRB)c.3472A>G,p.Ser1158Gly、磷脂酰肌醇-3-激酶调节亚基 3 c.121C>T,p.Pro41Ser、精神分裂症 1(DISC1)c.1591G>C p.Gly531Arg 与家族性 GD 相关。然后,我们进一步证实了这些变体,并研究了其他突变是否使 GD 易感。病例对照研究收集了散发性 GD 患者或无 GD 家族史的患者。使用快照程序对 235 名 GD 患者(GD 组 1)和 284 名健康患者(对照组)的选定 SNPs 进行基因分型。此外,招募了另外 184 名 GD 患者(GD 组 2)对这些基因的指定外显子进行测序。将测序数据与中国百万基因组数据库(CMDB)进行比较。在 GD 组 2 中发现了 PTPRB、磷脂酰肌醇-3-激酶调节亚基 3、TRAF3IP3 和 DISC1 的几个变体,但在 CMDB 中未发现。此外,GD 组 2 中 SNP rs2076150(TRAF3IP3)和 rs2492367 DISC1 的等位基因频率明显高于 CMDB(均 P<.05)。当以对照组或 CMDB 作为参考组时,GD 组 1 和 GD 组(由 GD 组 1 和 GD 组 2 组成)中 SNP rs186466118 的 PTPRB 等位基因 C 的频率明显更高。同样重要的是,SNP rs186466118 的等位基因 C 与 GD 易感性增加的风险之间存在相关性(均 P<.05)。PTPRB、TRAF3IP3 和 DISC1 可能是 GD 的易感基因,并且在 GD 患者中发现了更多的 PTPRB、TRAF3IP3 和 DISC1 变体。